Preclinical studies have shown decreased regulatory T cells, increased early activated and proliferating CD8+ tumor-infiltrating lymphocytes, tumor-infiltrating natural killer (NK) cells, tumor-associated dendritic cells, and mature dendritic cells [3, 5, 6]. Here, CD8A is linked to neoplasm.